About
Antibodies, Hybridomas, Research products
Areas of Focus
Categories
Non-PharmaceuticalAntibodyMidwest
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
11
As Collaborator
2
Total Enrollment
1,851
By Phase
NA: 1PHASE2: 6PHASE1: 3PHASE3: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 6UNKNOWN: 4TERMINATED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06531876Collaborator
Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy
NAActive, not recruiting
78 participants
Started: Jul 1, 2024 · Completed: Dec 1, 2025
NCT05743816Collaborator
Neonatal Antimicrobial Resistance and Outcome
N/AUnknown
800 participants
Started: Jul 30, 2019 · Completed: Feb 29, 2024
NCT01034410Lead Sponsor
A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia
PHASE2Terminated
90 participants
Started: Jan 31, 2010 · Completed: Jan 31, 2011
NCT01066494Lead Sponsor
A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
PHASE2Unknown
20 participants
Started: Jan 31, 2010 · Completed: Jan 31, 2011
NCT00770354Lead Sponsor
Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer
PHASE2Terminated
110 participants
Started: Sep 30, 2008 · Completed: Aug 31, 2011
Locations (1)
Headquarters
St. Peters, MO, United States
Map
Loading map...